首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1613807篇
  免费   110709篇
  国内免费   2668篇
耳鼻咽喉   23562篇
儿科学   52918篇
妇产科学   46327篇
基础医学   235942篇
口腔科学   45326篇
临床医学   135573篇
内科学   317559篇
皮肤病学   36415篇
神经病学   131570篇
特种医学   63641篇
外国民族医学   416篇
外科学   247568篇
综合类   28386篇
现状与发展   1篇
一般理论   408篇
预防医学   115243篇
眼科学   36548篇
药学   121171篇
  1篇
中国医学   3335篇
肿瘤学   85274篇
  2021年   12492篇
  2019年   13039篇
  2018年   19744篇
  2017年   14872篇
  2016年   17200篇
  2015年   18709篇
  2014年   24570篇
  2013年   37410篇
  2012年   52621篇
  2011年   55884篇
  2010年   32326篇
  2009年   29129篇
  2008年   53361篇
  2007年   57410篇
  2006年   57546篇
  2005年   56796篇
  2004年   54197篇
  2003年   52970篇
  2002年   51841篇
  2001年   68338篇
  2000年   70771篇
  1999年   59023篇
  1998年   17239篇
  1997年   15268篇
  1996年   15034篇
  1995年   14036篇
  1994年   13283篇
  1992年   44277篇
  1991年   43493篇
  1990年   42881篇
  1989年   41465篇
  1988年   38505篇
  1987年   37741篇
  1986年   35920篇
  1985年   34390篇
  1984年   25720篇
  1983年   22341篇
  1982年   13586篇
  1979年   24347篇
  1978年   17196篇
  1977年   14953篇
  1976年   14033篇
  1975年   15572篇
  1974年   18137篇
  1973年   17433篇
  1972年   16560篇
  1971年   15409篇
  1970年   14304篇
  1969年   13776篇
  1968年   12971篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
2.
3.
4.
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered.  相似文献   
5.
6.
7.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
8.
9.
10.
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号